Updated Jul 16, 2026
Kaye Randall is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $984K.
Randall Kaye is an executive in the pharmaceutical industry, currently serving as the Executive Vice President and Chief Medical Officer at Longboard Pharmaceuticals, Inc. He has been involved in several SEC filings related to his role at the company.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-12-02 | LBPH | Longboard Pharmaceuticals, Inc. | J — Other acquisition / disposition | 30.6K | $60.00 | $1.83M |
| 2024-11-19 | LBPH | Longboard Pharmaceuticals, Inc. | M — Option exercise | 30.6K | $6.00 | $183K |
| 2024-10-16 | LBPH | Longboard Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 16.7K | $59.03 | $984K |
| 2024-10-16 | LBPH | Longboard Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 16.7K | $4.35 | $73K |
Randall Kaye is an executive in the pharmaceutical industry, currently serving as the Executive Vice President and Chief Medical Officer at Longboard Pharmaceuticals, Inc. He has been involved in several SEC filings related to his role at the company.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($984K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kaye Randall profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.